MedTrace Logo

Virtual Reality Distraction for Reduction

NCT04416555 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 113

Last updated 2023-11-27

Study results available
· View outcomes & findings →

Summary

Using a randomized controlled design, the investigators goal is to estimate the effect of VR on postoperative analgesia and opioid consumption.

Conditions

  • Postoperative Pain

Interventions

DEVICE

Placebo comparator: VR googles and the non reality experience

parallel assignment (this arm will receive a static presentation in the same device)

DEVICE

Active Comparator: VR googles and the real VR program to enter act with and experience

Parallel assignment (this arm will receive the full immersive virtual reality experience

Sponsors & Collaborators

  • National Institute on Drug Abuse (NIDA)

    collaborator NIH

  • The Cleveland Clinic

    lead OTHER

Principal Investigators

  • Sabry Ayad, MD · The Cleveland Clinic

Study Design

Allocation
RANDOMIZED
Purpose
SUPPORTIVE_CARE
Masking
DOUBLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
85 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2020-08-03
Primary Completion
2022-04-25
Completion
2022-05-03
FDA Device
Yes

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04416555 on ClinicalTrials.gov